Shaun Mehr, Associate Publisher, Author at Onco'Zine

Home Authors Posts by Shaun Mehr, Associate Publisher

1796 POSTS 0 COMMENTS

https://sunvalleycommunication.com

Onco'Zine | ADC Review

Seattle Genetics Submits New Drug Application to the U.S. FDA for...

Peter Hofland, Ph.D - December 23, 2019

Study Shows Gender Differences Play a Role in Lack of Human...

Shaun Mehr, Associate Publisher - March 30, 2018

Study Suggest Women Still Need Cervical Cancer Screening After Age 65

Peter Hofland, Ph.D - March 30, 2018

FDA Takes Steps to Lower Nicotine in Cigarettes to Non-Addictive Levels

Shaun Mehr, Associate Publisher - March 20, 2018

The Power of The Immune System

Peter Hofland, Ph.D - March 3, 2018

Physicians Sue over Monopolistic ?Maintenance of Certification?

Alieta Eck - February 20, 2018

Can Corporate Heavyweights Really Tackle the Healthcare Issue?

Shaun Mehr, Associate Publisher - February 2, 2018

Researchers Demonstrate Effectiveness of CAR-T Therapy of ALL in Children and...

Peter Hofland, Ph.D - February 1, 2018

Clinical Trial with Novel Cancer Immunotherapy Targeting Brachyury in Cancer Metastasis...

Peter Hofland, Ph.D - January 19, 2018

First Patients Enrolled in Landmark Lung Cancer Tri-Therapy Clinical Trial

Peter Hofland, Ph.D - January 19, 2018

12 3...180 Page 1 of 180

LATEST NEWS

Cervical Cancer May Increase Risk of Injury During Diagnostic Workup

Peter Hofland, Ph.D - October 21, 2020

Treatment Informed by DetermaRx Significantly Improves Lung Cancer Survival

Editorial Team - October 19, 2020

ctDNA Predicts Outcomes with Checkpoint Inhibition in Melanoma in First line, not Second-line

Peter Hofland, Ph.D - October 19, 2020

U.S. FDA Approves Venetoclax for the Treatment of Acute Myeloid Leukemia

Editorial Team - October 16, 2020

More Education is Needed to Increase Provider Geriatric Assessments for Older Adults with Cancer

Editorial Team - October 16, 2020

Press Releases | Cancer

ARIZ Precision Medicine Discloses Major New Investor as Company... October 28, 2020
ARIZ Precision Medicine, The PRDM Oncogene Targeting Company™ announced that it has secured seed financing bringing total funding to date of $2.5 million. Proceeds will be used to expand the...(PRWeb October 28, 2020)Read the full story at https://www.prweb.com/releases/ariz_precision_medicine_discloses_major_new_investor_as_company_emerges_from_stealth_mode/prweb17501479.htm
Dracen Pharmaceutical’s DRP-104 Granted U.S. FDA Fast Track... October 27, 2020
Dracen to work closely with FDA to advance the clinical program for the treatment of NSCLC with specific mutations(PRWeb October 27, 2020)Read the full story at https://www.prweb.com/releases/dracen_pharmaceuticals_drp_104_granted_u_s_fda_fast_track_designation_for_the_treatment_of_non_small_cell_lung_cancer/prweb17497203.htm
11-Year Old Boy Inspires Cannabis Company to Raise $10,000 October 22, 2020
Giving Tree Dispensary is "Getting Their Grey On" by fundraising for 6 weeks for the National Brain Tumor Society.(PRWeb October 22, 2020)Read the full story at https://www.prweb.com/releases/11_year_old_boy_inspires_cannabis_company_to_raise_10_000/prweb17487235.htm